Table 1.
Characteristics of patients with cardiovascular hospitalisation and matched controls.
| Cases (n = 588) | Controls (n = 2920) | P value | |
|---|---|---|---|
| Systolic blood pressure, mmHg | 135.1 ± 12.9 | 134.0 ± 11.1 | 0.0264 |
| Diastolic blood pressure, mmHg | 73.0 ± 10.1 | 72.0 ± 10.0 | 0.0368 |
| Mean arterial pressure, mmHg | 94.1 ± 10.2 | 91.3 ± 9.2 | 0.0130 |
| Pulse pressure, mmHg | 62.1 ± 12.1 | 61.0 ± 12.0 | 0.0165 |
| Body mass index, kg/m2 | 30.4 ± 5.6 | 29.0 ± 5.8 | <0.0001 |
| HbA1c, mmol/mol (%) | 62 (7.8) ± 18 (1.6) | 57 (7.4) ± 14 (1.3) | <0.0001 |
| Total cholesterol, mmol/L | 4.1 ± 1.0 | 4.2 ± 1.0 | 0.0270 |
| Triglyceride, mmol/L | 2.0 ± 1.0 | 1.7 ± 0.9 | <0.0001 |
| High density lipoprotein, mmol/L | 1.1 ± 0.3 | 1.2 ± 0.4 | 0.0020 |
| Low density lipoprotein, mmol/L | 2.2 ± 0.8 | 2.4 ± 0.8 | 0.0060 |
| Estimated glomerular filtration rate, mL/min/1.73 m2 | 56.8 ± 18.9 | 56.6 ± 17.9 | 0.865 |
| Current smoker/ex-smoker | 66.9 | 65.8 | 0.623 |
| Pulse pressure, mmHg | 60.9 ± 14.9 | 61.9 ± 13.8 | 0.426 |
| Coronary heart disease history, % | 66.8 | 35.6 | <0.0001 |
| Cerebrovascular disease, % | 16.8 | 14.4 | 0.1320 |
| Lipid-lowering treatment, % | 86.9 | 72.2 | <0.0001 |
| Aspirin treatment, % | 66.9 | 53.7 | <0.0001 |